https://www.selleckchem.com/pr....oducts/abbv-2222.htm
at ClinicalTrials.gov (Identifier NCT04237259 ) on 14 February 2020. Protocol version 2; date, 23 June 2020. The study was registered at ClinicalTrials.gov (Identifier NCT04237259 ) on 14 February 2020. Protocol version 2; date, 23 June 2020. Vascular cell adhesion molecule-1 (VCAM-1) is involved in the progression of glomerular and tubulointerstitial injury in lupus nephritis (LN) and can be easily assessed in urine. The aim of this study was to assess urinary soluble VCAM-1 (uVCAM-1) as a biomarker of disease activity and treatment
Like
Comment
Share
